KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Interest Expenses (2016 - 2025)

Cme (CME) has disclosed Interest Expenses for 17 consecutive years, with $43.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 7.37% to $43.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $173.4 million, a 7.77% increase, with the full-year FY2025 number at $173.4 million, up 7.77% from a year prior.
  • Interest Expenses was $43.7 million for Q4 2025 at Cme, down from $44.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $44.0 million in Q2 2025 to a low of $39.6 million in Q3 2023.
  • A 5-year average of $41.2 million and a median of $40.6 million in 2022 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: fell 6.12% in 2023, then grew 9.73% in 2025.
  • Cme's Interest Expenses stood at $41.9 million in 2021, then dropped by 4.77% to $39.9 million in 2022, then decreased by 0.5% to $39.7 million in 2023, then rose by 2.52% to $40.7 million in 2024, then grew by 7.37% to $43.7 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Interest Expenses are $43.7 million (Q4 2025), $44.0 million (Q3 2025), and $44.0 million (Q2 2025).